Child & Adolescent Psychopharmacology 2020
This renowned conference provides a complete update across research, assessment and treatment of mental health conditions in children and adolescents. It is ideal if you work in mental health, primary care, nursing, psychology, school health and more.
Description
This renowned conference provides a complete update across research, assessment and treatment of mental health conditions in children and adolescents. It is ideal if you work in mental health, primary care, nursing, psychology, school health and more.
- Hear guidance on translating new research into clinical practice for substance use disorders, mood disorders, OCD, schizophrenia, anxiety disorders, and more
- Find sessions on pharmacologic treatments, psychological interventions, naturopathic treatments, suicide risk and prevention, implications of genetics, and much more
- Ask questions and discuss cases during Curbside Consultation hours with experts on specific topics
- Find insights that enhance your clinical work in psychiatric practices, community clinics, hospitals, school-based settings, primary care offices, university clinics, and psychology practices
Learning Objectives
At the end of this educational activity, participants should be able to:
- Describe the presentation, diagnosis, and current treatment options available for attention deficit and hyperactivity in childhood and adolescence
- Discuss the presentation, diagnosis, and current treatment options available for behavioral problems and pervasive developmental disorders
- Describe the presentation, diagnosis, and current treatment options available for depression, psychosis, manic depression, and anxiety
- Compare and contrast basic neuropharmacology, neuropsychological testing data, psychopharmacologic properties of compounds, and the implications of psychiatric genetics for guiding day-to-day pediatric psychopharmacology treatment
- Describe the risk management issues associated with adolescent substance use disorder and smoking, ethical and safe use of psychotropics, suicide risk and prevention, cardiovascular side effects and medical liability of stimulants, and liability prevention in psychopharmacology
- Explore the relationship among ADHD, PTSD, and Traumatic Brain Injury including a discussion of the commonalities among the phenotypes and distinguishing features
- Analyze emotional dysregulation and executive function in the context of ADHD
- Describe the relationship between antidepressants and suicide risk
- Discuss the available naturopathic treatments for emotional dysregulation in youth, including pros, cons, and available evidence
- Examine the evidence base for the Pediatric Autoimmune Neurological Disorder Associated with Streptococcus symptoms and its relation to OCD
- Describe the presentation, diagnosis, and current treatment options available for childhood onset schizophrenia
- Compare and contrast psychotherapeutic treatment approaches for children including DBT, CBT, and others
- Explore how animal models provide insight into child and adolescent psychiatric conditions, using ADHD as a model system
- Compare and contrast emotional dysregulation from mania, including presentation, course, and treatment
- Examine the relationship between learning disorders and ADHD
- Describe adult ADHD and discuss the controversies surrounding its diagnosis and treatment
- Examine the legal issues involved in treating individuals with ADHD and related disorders
- Describe the problems associated with treatment non-adherence and provide strategies to improve adherence in the clinical setting
